Search research articles
Contact Us
Filters
Showing results (331-340 of 407) with videos related to
Page
of 41
Sort By:
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
March 27, 2007
The tumor suppressor Wnt inhibitory factor 1 is frequently methylated in nasopharyngeal and esophageal carcinomas
Stephen L Chan, Yan Cui, Andrew van Hasselt, et al.
The Lancet. Oncology
|
January 19, 2015
Chemoradiotherapy with or without panitumumab in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-1): a randomised, controlled, open-label phase 2 trial
Ricard Mesía, Michael Henke, Andre Fortin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 17, 2026
A multicentre phase 2 study of trifluridine/tipiracil in recurrent/metastatic platinum resistant nasopharyngeal carcinomas
Jia Li Low, Wan Qin Chong, Edwin Pun Hui, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
December 31, 2021
Identifying optimal clinical trial candidates for locoregionally advanced nasopharyngeal carcinoma: Analysis of 9468 real-world cases and validation by two phase 3 multicentre, randomised controlled trial
Si-Qi Tang, Lei Chen, Wen-Fei Li, et al.
Carcinogenesis
|
October 22, 2009
Cucurbitacin I elicits anoikis sensitization, inhibits cellular invasion and in vivo tumor formation ability of nasopharyngeal carcinoma cells
Vivian W Y Lui, Daisy M S Yau, Elaine Y L Wong, et al.
Infection Control and Hospital Epidemiology
|
April 26, 2016
Emergence of Carbapenem-Resistant Acinetobacter baumannii in Nursing Homes With High Background Rates of MRSA Colonization
Vincent C C Cheng, Jonathan H K Chen, W C Ng, et al.
Oncogene
|
June 5, 2007
Epigenetic identification of ADAMTS18 as a novel 16q23.1 tumor suppressor frequently silenced in esophageal, nasopharyngeal and multiple other carcinomas
H Jin, X Wang, J Ying, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 12, 2004
Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nonnasopharyngeal head and neck carcinomas
Kwok Hung Yu, Y M Dennis Lo, Gary M Tse, et al.
Clinical Chemistry
|
October 16, 2012
Cancer genome scanning in plasma: detection of tumor-associated copy number aberrations, single-nucleotide variants, and tumoral heterogeneity by massively parallel sequencing
K C Allen Chan, Peiyong Jiang, Yama W L Zheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 5, 2022
Exploratory Study of NPC-0501 Trial: Optimal Cisplatin Dose of Concurrent and Induction/Adjuvant Chemotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma
Wai-Tong Ng, Cheuk-Wai Choi, Barton But, et al.
Page
of 41
Search research articles
Search
Showing results (331-340 of 407) with videos related to
Sort By:
Page
of 41
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
March 27, 2007
The tumor suppressor Wnt inhibitory factor 1 is frequently methylated in nasopharyngeal and esophageal carcinomas
Stephen L Chan, Yan Cui, Andrew van Hasselt, et al.
The Lancet. Oncology
|
January 19, 2015
Chemoradiotherapy with or without panitumumab in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-1): a randomised, controlled, open-label phase 2 trial
Ricard Mesía, Michael Henke, Andre Fortin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 17, 2026
A multicentre phase 2 study of trifluridine/tipiracil in recurrent/metastatic platinum resistant nasopharyngeal carcinomas
Jia Li Low, Wan Qin Chong, Edwin Pun Hui, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
December 31, 2021
Identifying optimal clinical trial candidates for locoregionally advanced nasopharyngeal carcinoma: Analysis of 9468 real-world cases and validation by two phase 3 multicentre, randomised controlled trial
Si-Qi Tang, Lei Chen, Wen-Fei Li, et al.
Carcinogenesis
|
October 22, 2009
Cucurbitacin I elicits anoikis sensitization, inhibits cellular invasion and in vivo tumor formation ability of nasopharyngeal carcinoma cells
Vivian W Y Lui, Daisy M S Yau, Elaine Y L Wong, et al.
Infection Control and Hospital Epidemiology
|
April 26, 2016
Emergence of Carbapenem-Resistant Acinetobacter baumannii in Nursing Homes With High Background Rates of MRSA Colonization
Vincent C C Cheng, Jonathan H K Chen, W C Ng, et al.
Oncogene
|
June 5, 2007
Epigenetic identification of ADAMTS18 as a novel 16q23.1 tumor suppressor frequently silenced in esophageal, nasopharyngeal and multiple other carcinomas
H Jin, X Wang, J Ying, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 12, 2004
Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nonnasopharyngeal head and neck carcinomas
Kwok Hung Yu, Y M Dennis Lo, Gary M Tse, et al.
Clinical Chemistry
|
October 16, 2012
Cancer genome scanning in plasma: detection of tumor-associated copy number aberrations, single-nucleotide variants, and tumoral heterogeneity by massively parallel sequencing
K C Allen Chan, Peiyong Jiang, Yama W L Zheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 5, 2022
Exploratory Study of NPC-0501 Trial: Optimal Cisplatin Dose of Concurrent and Induction/Adjuvant Chemotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma
Wai-Tong Ng, Cheuk-Wai Choi, Barton But, et al.
Page
of 41